GL1X · GenesisL1 explorer

MolNFT v1 · #106605 · protein

The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.

4THN: “The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.”. X-ray diffraction, 1 ligand (NAG), 1 pocket (best druggability 0.42). MolNFT v1 #106605 on GenesisL1: 3D structure…

PDB
4THN
Type
protein
Length
303 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-thrombin; Hirunorm IV
EC
3.4.21.5
UniProt
P00734
Ligands
NAG
Pockets
1 · best druggability 0.42

Structure

x-ray diffraction · 3 distinct chains · 17% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAlpha-thrombin (EC 3.4.21.5)protein3628% helix, 8% strandP00734
HAlpha-thrombin (EC 3.4.21.5)protein25316% helix, 36% strandP00734
IHirunorm IVprotein1421% helix, 7% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.420.7521empty

Interfaces

2 interfaces between chains.

  • L–H · 1442 Ų buried · 31 hydrogen bonds · protein-protein
  • H–I · 1088 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 modified, 4 disulfide, 1 d-amino, 1 glycan (nonstandard, disulfide, D-amino acid, N-glycosylation).

Compared structures

  • 4THN · The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.